Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Platform symbols : Snynf save search
BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
pipeline key platform
Alnylam Highlights Significant Progress with Platform Innovation and Clinical Pipeline at R&D Day
Published: 2023-12-13 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.14%
H: 4.22%
C: 3.97%
day innovation pipeline platform
BPGbio Wins 2023 BioTech Breakthrough Award for Therapeutics Platform of The Year
Published: 2023-11-08 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
award biotech year therapeutics platform
AssetMark Reports $96.2B Platform Assets for First Quarter 2023 – GlobeNewswire
Published: 2023-05-03 (Crawled : 21:00) - spacfeed.com
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
platform
Dotmatics Scientific R&D Platform Introduces Built-in GraphPad Prism Integrations
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
prism platform
ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
collaboration therapeutics platform
Entact Bio Draws $81M Financing for Protein Enhancement Platform (Updated)
Published: 2022-12-06 (Crawled : 00:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.74%
H: 8.46%
C: 8.46%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
platform
Entact Bio Draws $81M Financing for Protein Enhancement Platform
Published: 2022-12-06 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.74%
H: 8.46%
C: 8.46%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
platform
Empatica receives new FDA clearance for its Health Monitoring Platform and announces Series B financing
Published: 2022-11-22 (Crawled : 21:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
fda clearance health platform
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Published: 2022-11-04 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.25%
H: 0.11%
C: -1.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.27%
H: 8.9%
C: 6.93%
pharma trial results platform
OncoHost Announces New Executive Appointments Ahead of Imminent Launch of its Precision Oncology Platform
Published: 2022-10-03 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
platform
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
Published: 2022-09-05 (Crawled : 08:00) - biospace.com/
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
IPHYF | $2.65 104.6% 300
|
Health Technology
| Email alert
Add to watchlist
pharma platform phase 2b
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform
Published: 2022-07-25 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
technology therapeutics sanofi platform
SalioGen Therapeutics Strengthens its Leadership Team to Advance its Gene Coding™ Platform
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
therapeutics platform
ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M
Published: 2022-06-29 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
genetic therapeutics platform
ZS Launches ZAIDYN™ Clinical Development, Expanding Its Digital Life Sciences Platform
Published: 2022-06-17 (Crawled : 04:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
sciences life platform
Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.55%
H: 0.0%
C: -0.12%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
antibody sanofi platform
Genuv Teams With Aiforia to Create an AI-Powered Version of its ATRIVIEW® Drug Screening Platform
Published: 2022-02-15 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.0%
H: 0.99%
C: 0.47%
atriview drug platform
Kymera Discloses New KT-474 Clinical Data, Unveils New Development Program, Provides Oncology Pipeline as well as Platform and Discovery Updates, and Outlines 5-year Vision and Goals at 2021 R&D Day
Published: 2021-12-16 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -5.02%
H: 5.6%
C: 0.96%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 5.87%
H: 1.42%
C: -10.97%
kt-474 als platform
Sanofi Taps Millions Into AI Platform for Cancer Drug Discovery
Published: 2021-11-18 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.39%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.49%
H: 0.1%
C: -0.49%
cancer drug cancer drug discovery drug platform
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.